Preparation of a Specific Antibody to Each One of Catecholamines and L-Dopa.

Chemical and Pharmaceutical Bulletin - Japan
doi 10.1248/cpb.24.1422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Adjuvants to L-Dopa for Parkinsonism.

BMJ
1970English

Failure of Vitamin B6 to Reverse the L-Dopa Effect in Patients on a Dopa Decarboxylase Inhibitor

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1971English

Delayed O-Methylation of L-Dopa in MB-COMT-deficient Mice After Oral Administration of L-Dopa and Carbidopa

Xenobiotica
PharmacologyBiochemistryMutagenesisHealthMedicineToxicology
2017English

Suppression of Antibody and T Cell Proliferative Responses to L- Glutamic Acid60-L-Alanine30-L-Tyrosine10 by a Specific Monoclonal T Cell Factor

Journal of Experimental Medicine
MedicineAllergyImmunology
1980English

Selegiline (L-Deprenyl) and L-Dopa Treatment of Parkinson's Disease: A Double-Blind Trial.

Internal Medicine
Internal MedicineMedicine
1994English

The Structure of L-Mimosine, an L-Dopa Analogue.

Acta Chemica Scandinavica
1973English

L-Dopa Methyl Ester Antagonizes Competitively L-Dopa-Induced Facilitation of Noradrenaline Release From Rat Hypothalamic Slices.

The Japanese Journal of Pharmacology
1990English

L-Dopa for Parkinson's Disease - A Bittersweet Pill

European Journal of Neuroscience
Neuroscience
2018English

Hypotension Caused by L-Dopa.

BMJ
1970English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy